Search research articles
Contact Us
Filters
Showing results (331-340 of 785) with videos related to
Page
of 79
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 10, 2013
Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients
Christiane Drechsler, Andreas Schneider, Lena Gutjahr-Lengsfeld, et al.
Clinical Chemistry
|
March 19, 2025
Carbamylated Albumin, Heart Failure, and Mortality in Patients Undergoing Coronary Angiography
Babak Yazdani, Graciela E Delgado, Anders H Berg, et al.
Circulation. Heart Failure
|
November 19, 2009
Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors
Gülmisal Güder, Stefan Frantz, Johann Bauersachs, et al.
Kidney International
|
December 22, 2016
Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
Raphael Schiffmann, Derralynn A Hughes, Gabor E Linthorst, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 23, 2009
Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis
Vera Krane, Fritz Heinrich, Malte Meesmann, et al.
Circulation
|
January 21, 2009
Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment
Frank Weidemann, Markus Niemann, Frank Breunig, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
September 30, 2020
Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories: <i>Post Hoc</i> Analysis of a Randomized, Double-Blind, Placebo-Controlled, Multinational Trial
Adeera Levin, Vlado Perkovic, David C Wheeler, et al.
Clinical Kidney Journal
|
September 26, 2022
Soluble suppression of tumorigenesis-2 is a strong predictor of all-cause, cardiovascular and infection-related mortality risk in haemodialysis patients with diabetes mellitus
Fabian Hammer, Bernd Genser, Benjamin Dieplinger, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 3, 2022
Association of Serum Phosphate with Efficacy of Statin Therapy in Hemodialysis Patients
Ziad A Massy, Thomas Merkling, Sandra Wagner, et al.
Artificial Organs
|
November 14, 2012
Bisphenol A in chronic kidney disease
Detlef H Krieter, Bernard Canaud, Horst-Dieter Lemke, et al.
Page
of 79
Search research articles
Search
Showing results (331-340 of 785) with videos related to
Sort By:
Page
of 79
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 10, 2013
Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients
Christiane Drechsler, Andreas Schneider, Lena Gutjahr-Lengsfeld, et al.
Clinical Chemistry
|
March 19, 2025
Carbamylated Albumin, Heart Failure, and Mortality in Patients Undergoing Coronary Angiography
Babak Yazdani, Graciela E Delgado, Anders H Berg, et al.
Circulation. Heart Failure
|
November 19, 2009
Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors
Gülmisal Güder, Stefan Frantz, Johann Bauersachs, et al.
Kidney International
|
December 22, 2016
Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
Raphael Schiffmann, Derralynn A Hughes, Gabor E Linthorst, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 23, 2009
Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis
Vera Krane, Fritz Heinrich, Malte Meesmann, et al.
Circulation
|
January 21, 2009
Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment
Frank Weidemann, Markus Niemann, Frank Breunig, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
September 30, 2020
Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories: <i>Post Hoc</i> Analysis of a Randomized, Double-Blind, Placebo-Controlled, Multinational Trial
Adeera Levin, Vlado Perkovic, David C Wheeler, et al.
Clinical Kidney Journal
|
September 26, 2022
Soluble suppression of tumorigenesis-2 is a strong predictor of all-cause, cardiovascular and infection-related mortality risk in haemodialysis patients with diabetes mellitus
Fabian Hammer, Bernd Genser, Benjamin Dieplinger, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 3, 2022
Association of Serum Phosphate with Efficacy of Statin Therapy in Hemodialysis Patients
Ziad A Massy, Thomas Merkling, Sandra Wagner, et al.
Artificial Organs
|
November 14, 2012
Bisphenol A in chronic kidney disease
Detlef H Krieter, Bernard Canaud, Horst-Dieter Lemke, et al.
Page
of 79